BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 50 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $31,000 | -43.6% | 15,456 | -42.2% | 0.01% | -20.0% |
| Q2 2015 | $55,000 | -83.9% | 26,756 | -77.7% | 0.01% | -72.2% |
| Q2 2014 | $341,000 | -6.8% | 119,822 | +100.0% | 0.04% | -14.3% |
| Q1 2014 | $366,000 | +73.5% | 59,911 | +19.1% | 0.04% | +55.6% |
| Q4 2013 | $211,000 | +29.4% | 50,299 | +28.7% | 0.03% | +3.8% |
| Q3 2013 | $163,000 | – | 39,085 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,486,711 | $6,764,000 | 0.42% |
| SENZAR ASSET MANAGEMENT, LLC | 1,910,476 | $3,706,323,000 | 0.41% |
| TOWERVIEW LLC | 160,000 | $310,000 | 0.16% |
| BVF INC/IL | 350,776 | $681,000 | 0.12% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 218,177 | $423,000 | 0.05% |
| EAGLE GLOBAL ADVISORS LLC | 272,072 | $528,000 | 0.02% |
| Spark Investment Management LLC | 70,500 | $136,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 203,170 | $394,000 | 0.01% |
| JW Asset Management, LLC | 8,611 | $17,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 147,281 | $286,000 | 0.01% |